NLM Digital Collections

Search

Start Over Genre Technical Report ✖Remove constraint Genre: Technical Report

2021. Health insurance exchanges: changes in benchmark plans and premiums and effects of automatic re-enrollment on consumers' costs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, November 2017
Subject(s):
Benchmarking
Consumer Behavior
Costs and Cost Analysis
Health Insurance Exchanges -- economics
Insurance, Health -- economics
Eligibility Determination
Financing, Personal
Humans
United States
United States.

2022. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, November 2017
Subject(s):
Drug Costs
Drug Industry -- economics
Economics, Pharmaceutical -- trends
Pharmaceutical Research -- economics
Pharmaceutical Research -- trends
Antitrust Laws
Biological Products -- economics
Drug Approval -- economics
Drug Development -- economics
Drug Development -- trends
Economic Competition
Forecasting
Orphan Drug Production -- economics
Taxes
Humans
United States
National Institutes of Health (U.S.)

2023. Medicare and Medicaid: CMS needs to fully align its antifraud efforts with the fraud risk framework : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Fraud -- prevention & control
Health Insurance Exchanges
Medicaid
Medicare
Risk Assessment
Risk Management
Fraud -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
State Children's Health Insurance Program (U.S.)

2024. Sexual violence: actions needed to improve DOD's efforts to address the continuum of unwanted sexual behaviors : report to the Committee on Armed Services, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Military Personnel
Sexual Harassment -- prevention & control
Sex Offenses -- prevention & control
Domestic Violence -- prevention & control
Organizational Policy
Risk Factors
Risk Reduction Behavior
Humans
United States
United States. Department of Defense.
Centers for Disease Control and Prevention (U.S.)

2025. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Data Collection
Government Regulation
Information Systems
Medicaid
Federal Government
Fraud -- prevention & control
Mandatory Reporting
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

2026. Social Security disability: additional measures and evaluation needed to enhance accuracy and consistency of hearings decisions : report to the Chairman, Subcommittee on Social Security, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Disability Evaluation
Social Security -- legislation & jurisprudence
Disabled Persons -- legislation & jurisprudence
Employment
Forecasting
Social Security -- trends
Humans
United States
United States. Social Security Administration.

2027. FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Device Approval -- standards
Equipment Safety
Federal Government
Forecasting
Government Regulation
Inservice Training
Humans
United States
United States. Food and Drug Administration.

2028. Generic drugs: FDA should make public its plans to issue and revise guidance on nonbiological complex drugs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Drug Approval
Drugs, Generic
Therapeutic Equivalency
Chemistry, Pharmaceutical
Doxorubicin
Drug Development
Enoxaparin
Glatiramer Acetate
Gluconates
Propofol
Humans
United States
United States. Food and Drug Administration.

2029. Medicaid: CMS should take additional steps to improve assessments of individuals' needs for home- and community-based services : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Community Health Services
Eligibility Determination -- methods
Health Services Needs and Demand
Home Care Services
Medicaid
Needs Assessment
Conflict of Interest
Managed Care Programs
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

2030. Medicare Part B: Medicare represented at least half of the market for 22 of the 84 most expensive drugs in 2015 : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, December 2017
Subject(s):
Drug Costs
Health Care Sector
Health Expenditures
Medicare Part B -- economics
Insurance, Health, Reimbursement
Medicare Part B -- statistics & numerical data
Humans
United States